[1]
2025. An Interim Analysis of a Prospective Observational Study of Upadacitinib in Patients with Atopic Dermatitis with Prurigo Nodules. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s623. DOI:https://doi.org/10.25251/43885276.